Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ERO1B - Pancreatic ductal adenocarcinoma tumor and adjacent non-tumor tissue
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ERO1B - Type 2 diabetic and hyperglycemic pancreatic islets
ERO1B - Insulin-Producing Cells generated from dedifferentiated pancreatic islet cells expanded in vitro
ERO1B - Barrett esophagus: endoscopic biopsies
ERO1B - Polycystic ovary syndrome: proliferative phase endometrial cell types
ERO1B - True interval breast cancer
ERO1B - Rapamycin-resistant diffuse large B-cell lymphoma cell lines
ERO1B - Cancer stem cell population in highly metastatic variants of MDA-MB-231 breast cancer cell line
ERO1B - Myelomatous bone marrow cultures: contact versus contactless conditions
ERO1B - Transcription factor Pax5 overexpression in Hodgkin lymphoma cell line L428
ERO1B - Monoclonal gammopathies: bone marrow plasma cells
GEO DataSets Gene Chromosome neighbors Homologene neighbors
ERO1B - Mycobacterium tuberculosis H37Rv-infected macrophages response to vitamin D
ERO1B - Androgen effect on carboxyl terminal-binding protein 2-deficient prostate cancer cell line
ERO1B - HIV envelope protein gp120 effect on activated B cells from healthy donors: time course
ERO1B - Human polyomavirus JC virus (JCV) infection of clonal immortalized glial SVG cells
ERO1B - Long-term octreotide treatment of neuroendocrine tumor cell line CNDT2.5
ERO1B - MLL2-depleted epidermal keratinocyte response to the induction of differentiation in vitro
ERO1B - Acute myeloid leukemia cell line Kasumi-1 response to dasatinib treatment and withdrawal
ERO1B - Interleukin-3 effect on acute myeloid leukemia patient mononuclear cells: time course
ERO1B - Oncogenic BRAF harboring melanoma cell line response to BRAF inhibition
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on